טוען...
Current targeted therapeutics against COVID-19: Based on first-line experience in China
SARS-CoV-2 is a novel strain, causing a global pandemic since the end of 2019. The majority of patients showed nonspecific symptoms such as fever, dry cough, and fatigue. Most patients have a good prognosis while some with severe conditions could rapidly progress to acute respiratory distress syndro...
שמור ב:
| הוצא לאור ב: | Pharmacol Res |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Ltd.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7192075/ https://ncbi.nlm.nih.gov/pubmed/32360585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2020.104854 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|